Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial

Blood (2023) 142 (Supplement 1): 76.

https://doi.org/10.1182/blood-2023-188904

Published: 2023

Journal Articles

Initial Report of Part B Phase 1/2 Efficacy and Safety Results for Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed Immune Thrombocytopenia

Nichola Cooper, A.J. Gerard Jansen, Robert Bird, Jiří Mayer, Michelle Sholzberg, Michael D. Tarantino, Mamta Garg, Paula F Ypma, Vickie McDonald, Charles Percy, Milan Košťál, Isaac Goncalves, Lachezar H. Bogdanov, Terry B Gernsheimer, Remco Diab, Mengjie Yao, Ahmed Daak, David J Kuter

Blood (2023) 142 (Supplement 1): 685.

https://doi.org/10.1182/blood-2023-177808

Published: 2023

Journal Articles

Predictors of Remission in Adults with Immune Thrombocytopenia Treated with Romiplostim

Adrian Newland, MA, FRCP, FRCPath, James B. Bussel, MD, Robert Bird, FRACP, FRCP, FRCPA, MBBS, MRCP, Donald M. Arnold, MD MSc, FRCPC, Craig M. Kessler, Jiří Mayer, Monica Tejeda Romero, Ann Janssens, Kejia Wang, PhD, Melissa Jeanne Eisen, MD

Blood (2018) 132 (Supplement 1): 735.

https://doi.org/10.1182/blood-2018-99-109791

Published: 2018

Journal Articles

Elevated LAG-3 Expression in the Tumor Microenvironement of Patients with DLBCL Is Associated with a Non-GCB Phenotype and Poor Prognosis

Colm Keane, MB BCh BAO PhD MBA, Soi C Law, PhD, Clare Gould, MBBS, Santiyagu Francis, PhD, Emad Uddin Abro, MBBS, FRACP, FRCPA, BSc(Hons), Joshua W.D. Tobin, MD, Simone Birch, MBBS, Grace Gifford, MD, Sara Gabreilli, William S. Stevenson, MBBS PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Anthony Gill, MD, Sanjiv Jain, MBBS, Donna Cross, Annette Hernadez, Sarah-Jane Halliday, Robert Bird, FRACP FRCP FRCPA MBBS MRCP, Mark Hertzberg, Maher K Gandhi, PhD

Blood (2018) 132 (Supplement 1): 1576.

https://doi.org/10.1182/blood-2018-99-112830

Published: 2018

Journal Articles

A Critical Role for Intratumoral and Circulating LAG3 in Classical Hodgkin Lymphoma: Analysis from the Rathl Prospective Phase III International Clinical Trial

Blood (2018) 132 (Supplement 1): 1621.

https://doi.org/10.1182/blood-2018-99-112008

Published: 2018

Journal Articles

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL

Frank Vari, David Arpon, Colm Keane, Mark S. Hertzberg, Dipti Talaulikar, Sanjiv Jain, Qingyan Cui, Erica Han, Josh Tobin, Robert Bird, Donna Cross, Annette Hernandez, Clare Gould, Simone Birch, Maher K. Gandhi

Blood (2018) 131 (16): 1809–1819.

https://doi.org/10.1182/blood-2017-07-796342

Published: 2018

Includes: Supplemental data

Journal Articles

A Novel Anti-Lymphoma Immune Evasion Mediated By the Interaction Between PD-1 Enriched NK-Cells and CD163+PD-L1+PD-L2+ Tumor Associated Macrophages, That Is More Prominent in Hodgkin Lymphoma Than Diffuse Large B-Cell Lymphoma

Maher K Gandhi, PhDFRACP FRCPath FRCP, David Arpon, Colm Keane, Erica Han, Josh Tobin, MD, Robert Bird, FRACP, FRCP, FRCPA, MBBS, MRCP, Mark S Hertzberg, MBBS PhD FRACP FRCPA, Marlene Self, Donna Cross, Annette Hernandez, BS, Frank Vari, PhD

Blood (2016) 128 (22): 918.

https://doi.org/10.1182/blood.V128.22.918.918

Published: 2016

Journal Articles

Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP),

Ann Janssens, MD, Michael D. Tarantino, MD, Robert Bird, MD, Maria Gabriella Mazzucconi, MD, Ralph Vincent V. Boccia, MD, Maria Fernanda Lopez-Fernandez, MD, Tomas Kozak, MD, Michael Steurer, MD, Peter A.W. Te Boekhorst, MD, PhD, Kerry Dillingham, MSc, Richard Lizambri, MD

Blood (2011) 118 (21): 3279.

https://doi.org/10.1182/blood.V118.21.3279.3279

Published: 2011

Journal Articles

Haemopoietic Improvement Following Iron Chelation for Transfusional Haemosiderosis in Patients with Haematopoietic Neoplasia and Aplastic Anaemia: An Observational Study

Stephen Opat, MBBS(Hons) FRACP FRCPA, Robert Bird, MD, Cecily J Forsyth, FRACP, FRCPA, Jeffrey Szer, MBBS, FRACP, Constantine S. Tam, MBBS, FRACP, FRCPA, Penelope Motum, MB BS PhD FRACP FRCPA, Mark A. Bentley, MBBS FRCPA FRACP

Blood (2011) 118 (21): 5050.

https://doi.org/10.1182/blood.V118.21.5050.5050

Published: 2011

Journal Articles

WT1 Expression Levels at Diagnosis and as a Marker of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukaemia (AML).

James X Gray, MD, PhD, Lyle McMillen, PhD, Russell Saal, MMedSc, Steven Lane, MBBS, Peter Mollee, MBBS, Robert Bird, MBBS, Devinder Gill, MBChB, Paula Marlton, MBBS

Blood (2009) 114 (22): 2639.

https://doi.org/10.1182/blood.V114.22.2639.2639

Published: 2009

Journal Articles

JAK2 V617F Mutation Status Predicts Thrombotic Complications, Including Arterial Thrombosis, in Patients with Essential Thrombocytosis (ET).

Helen Weston, MBBS, Robert Bird, MBBS, Vanessa Griffiths, BSc, Mark Jones, BSc, PhD, Karen Grimmett, BSc, Russell Saal, BSc, Anthony K. Mills, MBBS, Devinder Gill, MBBS, Paula Marlton, MBBS, Peter Mollee, MBBS

Blood (2007) 110 (11): 2551.

https://doi.org/10.1182/blood.V110.11.2551.2551

Published: 2007

Journal Articles

Aggressive Cutaneous Squamous Cell Carcinoma (SCC) in Chronic Lymphocytic Leukaemia (CLL).

Steven W. Lane, MBBS, Peter N. Mollee, MBBS MMedSc, Robert Bird, MBBS, Sandro Porceddu, MBBS, Devinder Gill, MBBS

Blood (2005) 106 (11): 4993.

https://doi.org/10.1182/blood.V106.11.4993.4993

Published: 2005

Journal Articles

Accelerated Delivery of Rituximab Is Safe on an Out-Patient Basis.

Helen J. Middleton, MBBS, Peter Mollee, MBBS, Robert Bird, MBBS, Anthony K. Mills, MBBS, Paula Marlton, MBBS, Devinder Gill, MBBS

Blood (2005) 106 (11): 4777.

https://doi.org/10.1182/blood.V106.11.4777.4777

Published: 2005

NARROW

Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial

Initial Report of Part B Phase 1/2 Efficacy and Safety Results for Bruton Tyrosine Kinase Inhibitor Rilzabrutinib in Patients with Relapsed Immune Thrombocytopenia

Predictors of Remission in Adults with Immune Thrombocytopenia Treated with Romiplostim

Elevated LAG-3 Expression in the Tumor Microenvironement of Patients with DLBCL Is Associated with a Non-GCB Phenotype and Poor Prognosis

A Critical Role for Intratumoral and Circulating LAG3 in Classical Hodgkin Lymphoma: Analysis from the Rathl Prospective Phase III International Clinical Trial

Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL

A Novel Anti-Lymphoma Immune Evasion Mediated By the Interaction Between PD-1 Enriched NK-Cells and CD163+PD-L1+PD-L2+ Tumor Associated Macrophages, That Is More Prominent in Hodgkin Lymphoma Than Diffuse Large B-Cell Lymphoma

Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP),

Haemopoietic Improvement Following Iron Chelation for Transfusional Haemosiderosis in Patients with Haematopoietic Neoplasia and Aplastic Anaemia: An Observational Study

WT1 Expression Levels at Diagnosis and as a Marker of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukaemia (AML).

JAK2 V617F Mutation Status Predicts Thrombotic Complications, Including Arterial Thrombosis, in Patients with Essential Thrombocytosis (ET).

Aggressive Cutaneous Squamous Cell Carcinoma (SCC) in Chronic Lymphocytic Leukaemia (CLL).

Accelerated Delivery of Rituximab Is Safe on an Out-Patient Basis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only